Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KATRINA ABUABARA

Allopathic & Osteopathic Physicians Dermatology

NPI
1558689216
CMS profile
1005700
Location
PHILADELPHIA, PA

General Payments · PY2023–2024

$27,125.68

  • Reported across 20 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$27,069.88

18 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $9,381.59 5
Incyte Corporation $9,178.27 7
Amgen Inc. $8,510.02 6

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $55.80 2
PY2024 $27,069.88 18

Payment records · PY2024 (18)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $192.66 05/30/2024 Travel and Lodging Undisputed 01/23/2026 1117488552 CMS
Amgen Inc. $652.27 05/30/2024 Travel and Lodging Undisputed 01/23/2026 1117488554 CMS
Amgen Inc. $146.09 05/31/2024 Food and Beverage Undisputed 01/23/2026 1117488556 CMS
Amgen Inc. $99.00 05/31/2024 Travel and Lodging Undisputed 01/23/2026 1117488558 CMS
Amgen Inc. $4,800.00 06/05/2024 Consulting Fee Undisputed 01/23/2026 1117488550 CMS
Amgen Inc. $2,620.00 09/24/2024 Consulting Fee Undisputed 01/23/2026 1117488560 CMS
GENZYME CORPORATION $8,200.00 03/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139637587 CMS
GENZYME CORPORATION $258.87 03/09/2024 Travel and Lodging Undisputed 01/23/2026 1139637589 CMS
GENZYME CORPORATION $741.54 03/09/2024 Travel and Lodging Undisputed 01/23/2026 1139637591 CMS
GENZYME CORPORATION $176.71 03/09/2024 Travel and Lodging Undisputed 01/23/2026 1139637593 CMS
GENZYME CORPORATION $4.47 05/16/2024 Food and Beverage Undisputed 01/23/2026 1139637521 CMS
Incyte Corporation $879.62 10/03/2024 Travel and Lodging Undisputed 01/23/2026 1141262775 CMS
Incyte Corporation $299.00 10/04/2024 Travel and Lodging Undisputed 01/23/2026 1141186660 CMS
Incyte Corporation $7.95 10/04/2024 Food and Beverage Undisputed 01/23/2026 1141186664 CMS
Incyte Corporation $10.75 10/04/2024 Food and Beverage Undisputed 01/23/2026 1141186668 CMS
Incyte Corporation $307.00 10/04/2024 Travel and Lodging Undisputed 01/23/2026 1141227418 CMS
Incyte Corporation $7,650.00 10/04/2024 Consulting Fee Undisputed 01/23/2026 1141262783 CMS
Incyte Corporation $23.95 10/04/2024 Food and Beverage Undisputed 01/23/2026 1141307893 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.